NFG
VRTX icon

Nations Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Nations Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
4,445
-45
-1% -$19.9K 0.11% 210
2026
Q1 		$2M Buy
4,490
+202
+5% +$94.2K 0.1% 218
2025
Q4 		$1.94M Sell
4,288
-2
-0% -$862 0.1% 212
2025
Q3 		$1.68M Buy
4,290
+74
+2% +$30.9K 0.1% 222
2025
Q2 		$1.88M Buy
4,216
+174
+4% +$80.2K 0.13% 188
2025
Q1 		$1.96M Buy
4,042
+74
+2% +$34.5K 0.15% 166
2024
Q4 		$1.6M Sell
3,968
-13
-0.3% -$6.03K 0.12% 202
2024
Q3 		$1.85M Buy
3,981
+226
+6% +$109K 0.13% 177
2024
Q2 		$1.76M Sell
3,755
-33
-0.9% -$14.3K 0.14% 165
2024
Q1 		$1.58M Buy
3,788
+468
+14% +$198K 0.13% 178
2023
Q4 		$1.35M Buy
3,320
+45
+1% +$16.6K 0.13% 191
2023
Q3 		$1.14M Buy
3,275
+145
+5% +$50.7K 0.11% 211
2023
Q2 		$1.1M Buy
3,130
+16
+0.5% +$5.39K 0.11% 221
2023
Q1 		$981K Buy
3,114
+87
+3% +$26.1K 0.1% 231
2022
Q4 		$874K Sell
3,027
-155
-5% -$47.2K 0.1% 242
2022
Q3 		$921K Sell
3,182
-744
-19% -$214K 0.13% 187
2022
Q2 		$1.11M Buy
3,926
+113
+3% +$30.2K 0.15% 170
2022
Q1 		$995K Buy
3,813
+1,365
+56% +$324K 0.12% 193
2021
Q4 		$538K Buy
+2,448
New +$476K 0.07% 283
2020
Q4 		– Sell
-1,526
Closed -$415K – 319
2020
Q3 		$415K Buy
+1,526
New +$421K 0.13% 194

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nations Financial Group's VRTX Position: Q2 2026 in Review

Nations Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 1% in Q2 2026, selling an estimated $19.9K and leaving 4,445 shares worth $2.21M. The position accounts for 0.11% of the portfolio, ranked #210.

Nations Financial Group first reported a position in VRTX in Q3 2020 and has held it in 20 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Nations Financial Group held 4,445 shares of Vertex Pharmaceuticals worth $2.21M as of Q2 2026.
  • Nations Financial Group sold 45 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.9K.
  • Vertex Pharmaceuticals made up 0.11% of Nations Financial Group's portfolio in Q2 2026, its #210 holding.
  • Nations Financial Group first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.